When does EASTWOOD BIO-MEDICAL CANADA (EBM.CA) report earnings?
EASTWOOD BIO-MEDICAL CANADA (EBM.CA) will report earnings on 2026-06-29.
EASTWOOD BIO-MEDICAL CANADA (EBM.CA) Forecast, Price Target & Analyst Ratings
TSX-V:EBM • CA27783W1059
Current stock price
0.7 CAD
-0.15 (-17.65%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EASTWOOD BIO-MEDICAL CANADA (EBM.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$0.70 to mean target of N/A, Based on 0 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
0.00%
EBM.CA is currently not analyzed by any analysts.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jun 29, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 867.9K -33.23% | 702.1K -19.10% | 782.1K 11.39% | |
| EBITDA YoY % growth | -426.3K -1,021.84% | -321.3K 24.63% | -256.8K 20.07% | |
| EBIT YoY % growth | -534.2K -268.67% | -428.8K 19.73% | -301.8K 29.62% | |
| Operating Margin | -61.55% | -61.07% | -38.59% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A